US Patent Issued to Bristol-Myers Squibb on Sept. 23 for "Amorphous and crystalline forms of IDO inhibitors" (California, Indiana, New Jersey, Wisconsin Inventors)

Posted On: 2025-09-23

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,195, issued on Sept. 23, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Amorphous and crystalline forms of IDO inhibitors" was invented by Jay Patrick Powers (Pacifica, Calif.), Hilary Plake Beck (Emerald Hills, Calif.), Maksim Osipov (Redwood City, Calif.), Maureen Kay Reilly (Burlingame, Calif.), Hunter Paul Shunatona (Oakland, Calif.), James Ross Walker (Verona, Wis.), Mikhail Zibinsky (Redwood City, Calif.), Tamar Rosenbaum (Princeton, N.J.), Ian Scott Young (Redwood City, Calif.), Jennifer Nelson (Kokomo, Ind.) and Petinka Vlahova (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Bristol-Myers Squibb on Sept. 23 for "Amorphous and crystalline forms of IDO inhibitors" (California, Indiana, New Jersey, Wisconsin Inventors)